After Heparin: A Roundtable on Ensuring the Safety of the U.S. Drug Supply
March 14, 2011
- March 15, 2011
The Pew Charitable Trusts
901 E St NW
DC, Washington 20004
The Pew Charitable Trusts will host a roundtable discussion addressing the safety of the U.S. drug supply. Expert presentations will be part of a larger conversation on the issues and solutions raised in a draft white paper entitled, After Heparin: Protecting Consumers from the Risks of Substandard and Counterfeit Drugs. Participants will be provided with this paper in advance of the conference.
Through an examination of today's drug manufacturing, distribution and oversight systems, After Heparin explores the possible pathways for substandard or counterfeit drugs to reach U.S. patients both within the legitimate supply chain as well as through illicit routes. The roundtable discussion will provide a platform for dialogue on this important public health matter in addition to informing the final white paper itself, which will be released following the roundtable.
Speakers and participants include members of pharmaceutical, distribution and retail pharmacy industries, as well as representatives from FDA, GAO, USP, Boards of Pharmacy, consumer groups and academic organizations.
Download a draft agenda.
For RSVP information, please contact Michelle Pilliod, email@example.com or (202) 544-7900
For media inquiries, please contact Linda Paris, firstname.lastname@example.org or (202) 540-6354